1. Increases in reimbursement for brand-name drugs in Part D Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018 Subject(s): Drug Costs -- trendsDrug Utilization -- trendsInsurance, Health, ReimbursementMedicare Part D -- economicsCost SharingForecastingHealth ExpendituresHumansUnited StatesUnited States. Department of Health and Human Services.
